Targeting hypoxia-inducible factors: therapeutic opportunities and challenges

X Yuan, W Ruan, B Bobrow, P Carmeliet… - Nature Reviews Drug …, 2024 - nature.com
Hypoxia-inducible factors (HIFs) are highly conserved transcription factors that are crucial for
adaptation of metazoans to limited oxygen availability. Recently, HIF activation and …

Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets

Y Zhao, W Xiong, C Li, R Zhao, H Lu, S Song… - … and Targeted Therapy, 2023 - nature.com
Hypoxia, characterized by reduced oxygen concentration, is a significant stressor that affects
the survival of aerobic species and plays a prominent role in cardiovascular diseases. From …

Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis

K Abe, M Ikeda, T Ide, T Tadokoro, HD Miyamoto… - Science …, 2022 - science.org
Clinical use of doxorubicin (DOX) is limited because of its cardiotoxicity, referred to as DOX-
induced cardiomyopathy (DIC). Mitochondria-dependent ferroptosis, which is triggered by …

Mitochondrial remodeling and ischemic protection by G protein–coupled receptor 35 agonists

GA Wyant, W Yu, IIP Doulamis, RS Nomoto, MY Saeed… - Science, 2022 - science.org
Kynurenic acid (KynA) is tissue protective in cardiac, cerebral, renal, and retinal ischemia
models, but the mechanism is unknown. KynA can bind to multiple receptors, including the …

Iron overload via heme degradation in the endoplasmic reticulum triggers ferroptosis in myocardial ischemia-reperfusion injury

HD Miyamoto, M Ikeda, T Ide, T Tadokoro… - Basic to Translational …, 2022 - jacc.org
Summary Ischemia-reperfusion (I/R) injury is a promising therapeutic target to improve
clinical outcomes after acute myocardial infarction. Ferroptosis, triggered by iron overload …

The roles of HIF-1α signaling in cardiovascular diseases

T Sato, N Takeda - Journal of cardiology, 2023 - Elsevier
Oxygen is essential for living organisms. Molecular oxygen binds to hemoglobin and is
delivered to every organ in the body. In several cardiovascular diseases or anemia, local …

Etomidate attenuates the ferroptosis in myocardial ischemia/reperfusion rat model via Nrf2/HO-1 pathway

Z Lv, X Zhang, X Zhang, J Zhang, R Liu - Shock, 2021 - journals.lww.com
Background: Ferroptosis has been found to play an important role in myocardial ischemia
reperfusion (MIR) injury (MIRI). This study aimed to explore whether the improvement effect …

The hypoxia-adenosine link during myocardial ischemia—reperfusion injury

W Ruan, X Ma, IH Bang, Y Liang, JD Muehlschlegel… - Biomedicines, 2022 - mdpi.com
Despite increasing availability and more successful interventional approaches to restore
coronary reperfusion, myocardial ischemia-reperfusion injury is a substantial cause of …

Clinical potential of hypoxia inducible factors prolyl hydroxylase inhibitors in treating nonanemic diseases

M Miao, M Wu, Y Li, L Zhang, Q Jin, J Fan… - Frontiers in …, 2022 - frontiersin.org
Hypoxia inducible factors (HIFs) and their regulatory hydroxylases the prolyl hydroxylase
domain enzymes (PHDs) are the key mediators of the cellular response to hypoxia. HIFs are …

The interplay between autophagy and NLRP3 inflammasome in ischemia/reperfusion injury

S Lv, H Liu, H Wang - International Journal of Molecular Sciences, 2021 - mdpi.com
Ischemia/reperfusion (I/R) injury is characterized by a limited blood supply to organs,
followed by the restoration of blood flow and reoxygenation. In addition to ischemia, blood …